Pulling SEC filings + quote and writing the call…
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Next earnings Aug 3, 2026 (after close) · consensus $-0.13 EPS, $41.6M rev
Last earnings -3.5% on 2026-05-07
$1.35
▼ -3.93%$1.40▲ +1.45%
over 1Y
L $1.12EODHDH $2.67
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-3.9%
1W+3.7%
1M+21.7%
3M+0.0%
YTD-23.9%
1Y+1.4%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 15 analysts
Buy
Unprofitable (net margin -341.5%).
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shows $160M in FY2025 revenue (+3.9% YoY), a -341.5% net margin, and -10214.5% ROE.
Sources: SEC EDGAR (CIK 0001299130, latest 10-Q filed 2026-05-08) · EODHD · as of 6/22/2026, 5:46:22 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.